Effects of risedronate in Runx2 overexpressing mice, an animal model for evaluation of treatment effects on bone quality and fractures. (Q51482952)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21455736%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

title

Effects of risedronate in Runx2 overexpressing mice, an animal model for evaluation of treatment effects on bone quality and fractures (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21455736%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21455736%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Valérie Geoffroy

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21455736%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Agnes Ostertag

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21455736%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

author name string

Eleftherios P Paschalis

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21455736%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Helene Libouban

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21455736%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Daniel Chappard

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21455736%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Magali Cros

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21455736%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Roger Phipps

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21455736%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Marie-Christine de Vernejoul

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21455736%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

language of work or name

English

0 references

publication date

1 April 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21455736%20AND%20SRC:MED&resulttype=core&format=json

Calcified Tissue International

27 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21455736%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

volume

88

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21455736%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21455736%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

page(s)

464-475

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21455736%20AND%20SRC:MED&resulttype=core&format=json

Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group

27 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00223-011-9480-6

Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-011-9480-6

Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-011-9480-6

Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-011-9480-6

Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-011-9480-6

Relationship between changes in bone mineral density and fracture risk reduction with antiresorptive drugs: some issues with meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-011-9480-6

Relationship between changes in BMD and nonvertebral fracture incidence associated with risedronate: reduction in risk of nonvertebral fracture is not related to change in BMD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-011-9480-6

Bone quality: where do we go from here?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-011-9480-6

The bone quality framework: determinants of bone strength and their interrelationships, and implications for osteoporosis management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-011-9480-6

Insights into material and structural basis of bone fragility from diseases associated with fractures: how determinants of the biomechanical properties of bone are compromised by disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-011-9480-6

Review of nonprimate, large animal models for osteoporosis research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-011-9480-6

Determination of rat vertebral bone compressive fatigue properties in untreated intact rats and zoledronic-acid-treated, ovariectomized rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-011-9480-6

Selective modification of bone quality by PTH, pamidronate, or raloxifene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-011-9480-6

Clinical review 1: Bisphosphonate use in childhood osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-011-9480-6

High bone resorption in adult aging transgenic mice overexpressing cbfa1/runx2 in cells of the osteoblastic lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-011-9480-6

Overexpression of Cbfa1 in osteoblasts inhibits osteoblast maturation and causes osteopenia with multiple fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-011-9480-6

Overexpression of the transcriptional factor Runx2 in osteoblasts abolishes the anabolic effect of parathyroid hormone in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-011-9480-6

Spectroscopic characterization of collagen cross-links in bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-011-9480-6

Osteoprotegerin Regulates Bone Formation through a Coupling Mechanism with Bone Resorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-011-9480-6

Sequential treatment of ovariectomized mice with bFGF and risedronate restored trabecular bone microarchitecture and mineralization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-011-9480-6

Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-011-9480-6

A method to assess the proportion of treatment effect explained by a surrogate endpoint

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-011-9480-6

Animal models for osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-011-9480-6

Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-011-9480-6

Inhibition of osteoblast function in vitro by aminobisphosphonates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-011-9480-6

Chemistry of collagen cross-linking: biochemical changes in collagen during the partial mineralization of turkey leg tendon

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-011-9480-6

Collagen cross-links in mineralizing tissues: a review of their chemistry, function, and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-011-9480-6

Effect of hormone replacement therapy on bone quality in early postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00223-011-9480-6